Skip to content

Clinical trials

Anemia, Refractory, with Excess of Blasts trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Refractory, with Excess of Blasts Clear all

317 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200019
200114
200214
200312
200416
200517
200612
200716
20087
200911
201012
20116
20128
201310
20147
20155
20165
20174
20188
20196
20209
20213
20226
20233
20244
202514
202615

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed190
Terminated46
Recruiting37
Active, not recruiting15
Unknown status15
Withdrawn7
Not yet recruiting6
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)26
Fred Hutchinson Cancer Center25
Masonic Cancer Center, University of Minnesota13
Memorial Sloan Kettering Cancer Center11
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins11
M.D. Anderson Cancer Center9
Case Comprehensive Cancer Center8
European Organisation for Research and Treatment of Cancer - EORTC7
National Heart, Lung, and Blood Institute (NHLBI)7
University of California, San Francisco7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Refractory, with Excess of Blasts317
Leukemia, Myeloid, Acute176
Myelodysplastic Syndromes169
Leukemia142
Leukemia, Myelomonocytic, Chronic125
Precursor Cell Lymphoblastic Leukemia-Lymphoma115
Myeloproliferative Disorders78
Anemia, Refractory77
Congenital Abnormalities67
Leukemia, Lymphocytic, Chronic, B-Cell65

Trials

Showing 51 to 75 of 317. Each trial links to its page on Pharma Observatory.

217 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.